259 related articles for article (PubMed ID: 16570926)
1. Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.
McBriar MD; Guzik H; Shapiro S; Paruchova J; Xu R; Palani A; Clader JW; Cox K; Greenlee WJ; Hawes BE; Kowalski TJ; O'neill K; Spar BD; Weig B; Weston DJ; Farley C; Cook J
J Med Chem; 2006 Apr; 49(7):2294-310. PubMed ID: 16570926
[TBL] [Abstract][Full Text] [Related]
2. Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.
McBriar MD; Guzik H; Xu R; Paruchova J; Li S; Palani A; Clader JW; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar B; Weig B
J Med Chem; 2005 Apr; 48(7):2274-7. PubMed ID: 15801820
[TBL] [Abstract][Full Text] [Related]
3. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.
Kowalski TJ; Spar BD; Weig B; Farley C; Cook J; Ghibaudi L; Fried S; O'Neill K; Del Vecchio RA; McBriar M; Guzik H; Clader J; Hawes BE; Hwa J
Eur J Pharmacol; 2006 Mar; 535(1-3):182-91. PubMed ID: 16540104
[TBL] [Abstract][Full Text] [Related]
4. Discovery of tetralin ureas as potent melanin concentrating hormone 1 receptor antagonists.
Guo T; Gu H; Hobbs DW; Busler DE; Rokosz LL
Bioorg Med Chem Lett; 2007 Mar; 17(6):1718-21. PubMed ID: 17251014
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists.
Wu WL; Burnett DA; Caplen MA; Domalski MS; Bennett C; Greenlee WJ; Hawes BE; O'Neill K; Weig B; Weston D; Spar B; Kowalski T
Bioorg Med Chem Lett; 2006 Jul; 16(14):3674-8. PubMed ID: 16690315
[TBL] [Abstract][Full Text] [Related]
6. Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity.
Souers AJ; Gao J; Brune M; Bush E; Wodka D; Vasudevan A; Judd AS; Mulhern M; Brodjian S; Dayton B; Shapiro R; Hernandez LE; Marsh KC; Sham HL; Collins CA; Kym PR
J Med Chem; 2005 Mar; 48(5):1318-21. PubMed ID: 15743174
[TBL] [Abstract][Full Text] [Related]
7. Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity.
Galiano S; Ceras J; Cirauqui N; Pérez S; Juanenea L; Rivera G; Aldana I; Monge A
Bioorg Med Chem; 2007 Jun; 15(11):3896-911. PubMed ID: 17407817
[TBL] [Abstract][Full Text] [Related]
8. New amide derivatives as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.
Cirauqui N; Ceras J; Galiano S; Pérez-Silanes S; Juanenea L; Rivera G; Aldana I; Monge A
Arzneimittelforschung; 2008; 58(11):585-91. PubMed ID: 19137910
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel phenethylpyridone derivatives as potent melanin-concentrating hormone 1 receptor antagonists.
Ando M; Sekino E; Haga Y; Moriya M; Ito M; Ito J; Iwaasa H; Ishihara A; Kanatani A; Ohtake N
Bioorg Med Chem Lett; 2009 Sep; 19(17):5186-90. PubMed ID: 19632840
[TBL] [Abstract][Full Text] [Related]
10. Melanin-concentrating hormone 1-receptor antagonist suppresses body weight gain correlated with high receptor occupancy levels in diet-induced obesity mice.
Ito M; Ishihara A; Gomori A; Egashira S; Matsushita H; Mashiko S; Ito J; Ito M; Nakase K; Haga Y; Iwaasa H; Suzuki T; Ohtake N; Moriya M; Sato N; MacNeil DJ; Takenaga N; Tokita S; Kanatani A
Eur J Pharmacol; 2009 Dec; 624(1-3):77-83. PubMed ID: 19836369
[TBL] [Abstract][Full Text] [Related]
11. Biaryl ureas as potent and orally efficacious melanin concentrating hormone receptor 1 antagonists for the treatment of obesity.
Palani A; Shapiro S; McBriar MD; Clader JW; Greenlee WJ; Spar B; Kowalski TJ; Farley C; Cook J; van Heek M; Weig B; O'neill K; Graziano M; Hawes B
J Med Chem; 2005 Jul; 48(15):4746-9. PubMed ID: 16033253
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists.
Suzuki T; Kameda M; Ando M; Miyazoe H; Sekino E; Ito S; Masutani K; Kamijo K; Takezawa A; Moriya M; Ito M; Ito J; Nakase K; Matsushita H; Ishihara A; Takenaga N; Tokita S; Kanatani A; Sato N; Fukami T
Bioorg Med Chem Lett; 2009 Sep; 19(18):5339-45. PubMed ID: 19683441
[TBL] [Abstract][Full Text] [Related]
13. Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists.
Xin Z; Serby MD; Zhao H; Kosogof C; Szczepankiewicz BG; Liu M; Liu B; Hutchins CW; Sarris KA; Hoff ED; Falls HD; Lin CW; Ogiela CA; Collins CA; Brune ME; Bush EN; Droz BA; Fey TA; Knourek-Segel VE; Shapiro R; Jacobson PB; Beno DW; Turner TM; Sham HL; Liu G
J Med Chem; 2006 Jul; 49(15):4459-69. PubMed ID: 16854051
[TBL] [Abstract][Full Text] [Related]
14. Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists.
Vasudevan A; Souers AJ; Freeman JC; Verzal MK; Gao J; Mulhern MM; Wodka D; Lynch JK; Engstrom KM; Wagaw SH; Brodjian S; Dayton B; Falls DH; Bush E; Brune M; Shapiro RD; Marsh KC; Hernandez LE; Collins CA; Kym PR
Bioorg Med Chem Lett; 2005 Dec; 15(23):5293-7. PubMed ID: 16203136
[TBL] [Abstract][Full Text] [Related]
15. Antiobesity effects of melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
Cheon HG
Handb Exp Pharmacol; 2012; (209):383-403. PubMed ID: 22249825
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists.
Sasmal PK; Sasmal S; Rao PT; Venkatesham B; Roshaiah M; Abbineni C; Khanna I; Jadhav VP; Suresh J; Talwar R; Muzeeb S; Receveur JM; Frimurer TM; Rist Ø; Elster L; Högberg T
Bioorg Med Chem Lett; 2010 Sep; 20(18):5443-8. PubMed ID: 20724156
[TBL] [Abstract][Full Text] [Related]
17. Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonists.
Kym PR; Iyengar R; Souers AJ; Lynch JK; Judd AS; Gao J; Freeman J; Mulhern M; Zhao G; Vasudevan A; Wodka D; Blackburn C; Brown J; Che JL; Cullis C; Lai SJ; LaMarche MJ; Marsilje T; Roses J; Sells T; Geddes B; Govek E; Patane M; Fry D; Dayton BD; Brodjian S; Falls D; Brune M; Bush E; Shapiro R; Knourek-Segel V; Fey T; McDowell C; Reinhart GA; Preusser LC; Marsh K; Hernandez L; Sham HL; Collins CA
J Med Chem; 2005 Sep; 48(19):5888-91. PubMed ID: 16161992
[TBL] [Abstract][Full Text] [Related]
18. Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.
Semple G; Tran TA; Kramer B; Hsu D; Han S; Choi J; Vallar P; Casper MD; Zou N; Hauser EK; Thomsen W; Whelan K; Sengupta D; Morgan M; Sekiguchi Y; Kanuma K; Chaki S; Grottick AJ
Bioorg Med Chem Lett; 2009 Nov; 19(21):6166-71. PubMed ID: 19773162
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1.
Rowbottom MW; Vickers TD; Dyck B; Grey J; Tamiya J; Zhang M; Kiankarimi M; Wu D; Dwight W; Wade WS; Schwarz D; Heise CE; Madan A; Fisher A; Petroski R; Goodfellow VS
Bioorg Med Chem Lett; 2006 Sep; 16(17):4450-7. PubMed ID: 16814542
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
Bioorg Med Chem Lett; 2008 Sep; 18(17):4859-63. PubMed ID: 18682323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
